| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Viral Immunology Laboratory, Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10021; and
Department of Molecular Biology, Beijing Institute of Microbiology and Epidemiology, Beijing, China
The spike (S) protein of severe acute respiratory syndrome associated coronavirus (SARS-CoV) is a major antigenic determinant capable of inducing protective immunity. Recently, a small fragment on the SARS-CoV S protein (residues 318–510) was characterized as a minimal receptor-binding domain (RBD), which mediates virus binding to angiotensin-converting enzyme 2, the functional receptor on susceptible cells. In this study, we demonstrated that a fusion protein containing RBD linked to human IgG1 Fc fragment (designated RBD-Fc) induced high titer of RBD-specific Abs in the immunized mice. The mouse antisera effectively neutralized infection by both SARS-CoV and SARS pseudovirus with mean 50% neutralization titers of 1/15,360 and 1/24,737, respectively. The neutralization determinants on the RBD of S protein were characterized by a panel of 27 mAbs isolated from the immunized mice. Six groups of conformation-dependent epitopes, designated as Conf I–VI, and two adjacent linear epitopes were identified by ELISA and binding competition assays. The Conf IV and Conf V mAbs significantly blocked RBD-Fc binding to angiotensin-converting enzyme 2, suggesting that their epitopes overlap with the receptor-binding sites in the S protein. Most of the mAbs (23 of 25) that recognized the conformational epitopes possessed potent neutralizing activities against SARS pseudovirus with 50% neutralizing dose ranging from 0.005 to 6.569 µg/ml. Therefore, the RBD of SARS S protein contains multiple conformational epitopes capable of inducing potent neutralizing Ab responses, and is an important target site for developing vaccines and immunotherapeutics.
This article has been cited by other articles:
|
|
 |
|
  Y. He, S. J. Barker, A. J. MacDonald, Y. Yu, L. Cao, J. Li, R. Parhar, S. Heck, S. Hartmann, D. T. Golenbock, et al. Recombinant Ov-ASP-1, a Th1-Biased Protein Adjuvant Derived from the Helminth Onchocerca volvulus, Can Directly Bind and Activate Antigen-Presenting Cells J. Immunol., April 1, 2009; 182(7): 4005 - 4016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-M. Chan, P. C. Y. Woo, S. K. P. Lau, H. Tse, H.-L. Chen, F. Li, B.-J. Zheng, L. Chen, J.-D. Huang, and K.-Y. Yuen Spike Protein, S, of Human Coronavirus HKU1: Role in Viral Life Cycle and Application in Antibody Detection Experimental Biology and Medicine, December 1, 2008; 233(12): 1527 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Du, G. Zhao, Y. Lin, H. Sui, C. Chan, S. Ma, Y. He, S. Jiang, C. Wu, K.-Y. Yuen, et al. Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection J. Immunol., January 15, 2008; 180(2): 948 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. C. C. Cheng, S. K. P. Lau, P. C. Y. Woo, and K. Y. Yuen Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection Clin. Microbiol. Rev., October 1, 2007; 20(4): 660 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-W. Lin, C.-W. Lo, S.-Y. Lai, R.-J. Fan, C.-J. Lo, Y.-m. Chou, R. Thiruvengadam, A. H.-J. Wang, and M.-Y. Wang Chicken Heat Shock Protein 90 Is a Component of the Putative Cellular Receptor Complex of Infectious Bursal Disease Virus J. Virol., August 15, 2007; 81(16): 8730 - 8741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zhu, S. Chakraborti, Y. He, A. Roberts, T. Sheahan, X. Xiao, L. E. Hensley, P. Prabakaran, B. Rockx, I. A. Sidorov, et al. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies PNAS, July 17, 2007; 104(29): 12123 - 12128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Liu, Q. Fang, F. Deng, H. Wang, C. E. Yi, L. Ba, W. Yu, R. D. Lin, T. Li, Z. Hu, et al. Natural Mutations in the Receptor Binding Domain of Spike Glycoprotein Determine the Reactivity of Cross-Neutralization between Palm Civet Coronavirus and Severe Acute Respiratory Syndrome Coronavirus J. Virol., May 1, 2007; 81(9): 4694 - 4700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-P. Shih, C.-Y. Chen, S.-J. Liu, K.-H. Chen, Y.-M. Lee, Y.-C. Chao, and Y.-M. A. Chen Identifying Epitopes Responsible for Neutralizing Antibody and DC-SIGN Binding on the Spike Glycoprotein of the Severe Acute Respiratory Syndrome Coronavirus. J. Virol., November 1, 2006; 80(21): 10315 - 10324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhou, D. Xu, X. Li, H. Li, M. Shan, J. Tang, M. Wang, F.-S. Wang, X. Zhu, H. Tao, et al. Screening and Identification of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific CTL Epitopes J. Immunol., August 15, 2006; 177(4): 2138 - 2145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Kuhn, S. R. Radoshitzky, A. C. Guth, K. L. Warfield, W. Li, M. J. Vincent, J. S. Towner, S. T. Nichol, S. Bavari, H. Choe, et al. Conserved Receptor-binding Domains of Lake Victoria Marburgvirus and Zaire Ebolavirus Bind a Common Receptor J. Biol. Chem., June 9, 2006; 281(23): 15951 - 15958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Prabakaran, J. Gan, Y. Feng, Z. Zhu, V. Choudhry, X. Xiao, X. Ji, and D. S. Dimitrov Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody J. Biol. Chem., June 9, 2006; 281(23): 15829 - 15836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. He, J. Li, S. Heck, S. Lustigman, and S. Jiang Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design. J. Virol., June 1, 2006; 80(12): 5757 - 5767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. He, J. Li, W. Li, S. Lustigman, M. Farzan, and S. Jiang Cross-Neutralization of Human and Palm Civet Severe Acute Respiratory Syndrome Coronaviruses by Antibodies Targeting the Receptor-Binding Domain of Spike Protein J. Immunol., May 15, 2006; 176(10): 6085 - 6092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Li, S.-K. Wong, F. Li, J. H. Kuhn, I-C. Huang, H. Choe, and M. Farzan Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus: Insight from ACE2-S-Protein Interactions J. Virol., May 1, 2006; 80(9): 4211 - 4219. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Maache, F. Komurian-Pradel, A. Rajoharison, M. Perret, J.-L. Berland, S. Pouzol, A. Bagnaud, B. Duverger, J. Xu, A. Osuna, et al. False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid-Based Western Blot Assay Were Rectified by the Use of Two Subunits (S1 and S2) of Spike for Detection of Antibody to SARS-CoV. Clin. Vaccine Immunol., March 1, 2006; 13(3): 409 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Li, Z. Shi, M. Yu, W. Ren, C. Smith, J. H. Epstein, H. Wang, G. Crameri, Z. Hu, H. Zhang, et al. Bats Are Natural Reservoirs of SARS-Like Coronaviruses Science, October 28, 2005; 310(5748): 676 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Li, W. Li, M. Farzan, and S. C. Harrison Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor Science, September 16, 2005; 309(5742): 1864 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Yi, L. Ba, L. Zhang, D. D. Ho, and Z. Chen Single Amino Acid Substitutions in the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Determine Viral Entry and Immunogenicity of a Major Neutralizing Domain J. Virol., September 15, 2005; 79(18): 11638 - 11646. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
